Jacob J. Adashek, DO
Jacob J. Adashek, DO, is a medical oncology fellow at the Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins Hospital. Dr. Adashek is particularly interested in precision medicine, personalized therapies, and first-in-human clinical trials. As a medical oncology fellow, he is being trained by world-renowned medical oncologists at the Johns Hopkins Hospital and caring for patients with a multitude of cancers. Dr. Adashek has published over 90 peer-reviewed articles in many prestigious journals, including Nature Clinical Reviews Oncology, JAMA Oncology, and among others. He has also presented his work at national and international conferences, including an oral presentation at the European Society for Medical Oncology Congress. Prior to starting his training at Johns Hopkins Hospital, Dr. Adashek was an internal medicine resident at the University of South Florida and Moffitt Cancer Center in Tampa. Before that, he completed a rigorous 7-year combined degree program, including an accelerated undergraduate degree at Pitzer College of the Claremont Colleges and a medical degree at Western University of Health Sciences in Pomona, California. In addition, he spent a year training in clinical research with a medical oncologist in the genitourinary oncology section of the City of Hope. Dr. Adashek is also a member of the American Society of Clinical Oncology and the American Association for Cancer Research.
Aseel Alsouqi, MD
Dr. Alsouqi is a third-year hematology/oncology fellow at the University of Pittsburgh Medical Center. She earned her medical degree from the University of Jordan Faculty of Medicine and completed her internal medicine residency training at Vanderbilt University Medical Center. Dr. Alsouqi is interested in aggressive non-Hodgkin lymphoma, particularly lymphoma involving the central nervous system. She was selected to participate in the ASCO/AACR Methods of Clinical Cancer Research Workshop in Vail to develop a clinical trial protocol in relapsed lymphoma after CAR-T therapy. She received the American Society of Hematology Summit on Immunotherapies abstract award for her work on reporting outcomes of CAR-T therapy in patients with secondary CNS lymphoma. She was also selected to participate in the Academy of Next Wave of Investigators in NHL and CLL. Dr. Alsouqi is pursuing a career as a clinical and translational investigator in CLL and lymphoma. She will study the mechanisms of resistance to cellular therapies in lymphoma and CLL and develop clinical trials using novel immune based- therapies to overcome this resistance.
Opadeyi Oluseyi Michael, MBBS
Dr. Opadeyi Oluseyi Michael is a Trainee Specialist in Haematology at the Lagos University Teaching Hospital, Lagos, Nigeria. He obtained his MBBS degree at the University of Ilorin and Proceeded with his postgraduate degree programme. He had his Junior residency examination in 2019 and was awarded a Membership of the West Africa College of Physician (Hematology) and National Postgraduate Medical College of Nigeria, in September 2023, He bagged a prize award at the National Postgraduate Medical College of Nigeria Part 2 examination as the best candidate at the FMCPath examination in Hematology. He has an interest in Haemoto- oncology, particularly in the management of Lymphoproliferative disease. He is motivated by the novel agents and Cancer immunotherapies employed in managing haematologic malignancies and is highly optimistic about having a very impactful and engaging session at the 2024 Cancer Immunotherapy Winter School (CIWS).